Basket | Login


LSP and Philip Scheltens launch new, unique fund to fight dementia

Tuesday 12 January 2021

On 12 January, European life sciences investor LSP (Life Sciences Partners) announced the launch of the LSP Dementia Fund, dedicated to fighting neurodegenerative diseases. The fund is being managed by world-renowned Dutch dementia researcher Professor Philip Scheltens (pictured). The LSP Dementia Fund will focus on all stages of development of dementia drugs and medtech (medical technology) and as such is the first of its kind in the world. The focus will be on finding novel treatments for different neurodegenerative diseases that cause dementia, as well as generating a financial return for investors. Prof. Scheltens said: "I am excited to make this move in my career to realise treatment options for patients, building on and combining it with the work I was able to do at the Alzheimer Center Amsterdam. I am very honoured to be a part of the LSP team, the largest and most experienced life sciences investor in Europe."